Thalassemia (alpha \[α\] and beta \[β\]) and sickle cell disease (SCD) are the most prevalent hemoglobin disorders in the Kingdom of Saudi Arabia.[@ref1]-[@ref11] Alpha-thalassemia (α-thal) is a disorder caused by the deletion of single or double α-globin genes, and/or point mutations in the α-globin genes.[@ref10] Alpha-thalassemia phenotype varies from very mild or microcytic hypochromic anemia to a lethal form of hemolytic anemia, depending on the type of molecular defects in α-globin genes.[@ref10] Alpha-globin genes are of 2 types; hemoglobin alpha 1 (*HBA1*) and hemoglobin alpha 2 (*HBA2*). The *HBA1* and *HBA2* genes are located in the p arm (short arm) of chromosome 16 at region one, band 3, and sub-band 3. Altogether there are 4 genes (α~1~α~2~/α~1~α~2~) in a person corresponding to 4 α-globin proteins. Out of the 4 α-globin genes, 2 are inherited from the father, and others from the mother. Loss of single or all of these genes results in different types of α-thal. The α-globin protein is a subunit of hemoglobin, which is a larger protein in red blood cells (RBC) that carries oxygen throughout the body. Alpha-globin proteins of *HBA2* and *HBA1* genes are nearly identical. Alpha-globin protein is subunit of fetal hemoglobin (HbF), which is active only in the human fetus and in the newborn period until roughly 6 months old. Exceptionally, in non-transfusion dependent β-thal cases, HbF is elevated and active throughout life. Reduced synthesis of α-globin protein ameliorates the clinical severity of β-thallassemia. Alpha-globin is an emerging molecular target for treatment of β-thal.[@ref12] Hence, it is essential to understand the different types of globin genes and its variants prevalent in Saudi population.

The α-globin genes in Saudis {#sec2-1}
============================

A number of research reports were available on the analysis of mutations and deletion in the α-globin genes from Saudi population.[@ref1]-[@ref11],[@ref13]-[@ref20] Commonly, α-globin genes are of 2 types (*HBA2* and *HBA1*), while in Saudis it is of 3 types namely *HBA2* (α~2~), *HBA1* (α~1~), and *HBA12* (α~12~).[@ref8] The *HBA12* is a new convert of the *HBA2* gene, discovered in Saudis. The *HBA2* has been replaced with *HBA12* in 5.7% of Saudi population.[@ref8] The poly A mutation \[AATAAA\>AATAAG\] (41%), and the α^3.7^ α^+^ heterozygous deletion are the most reported mutations and deletion in Saudi population. Co-inheritance of α-globin gene and β-globin gene mutations are prevalent in Saudis.[@ref7]-[@ref9]

The α-globin gene conversion {#sec2-2}
============================

A recent study by Borgio et al[@ref8] using direct sequencing of *HBA1* and *HBA2* in Saudis revealed a new gene, which was very closely related to the common α-globin genes (*HBA1* and *HBA2*). They named the new gene as *2*~.~ They clearly described that the formation the *HBA12* was formed by the combination of *HBA1* and *HBA2* gene sequences through a process called gene conversion ([**Figure 1**](#F1){ref-type="fig"}). Gene conversion is the process of the transfer of genetic material unidirectionally from a donor to an acceptor.[@ref21] Gene conversion between the 2 homologous α-globin genes is common.[@ref8] The *HBA12* gene has the region starting -6bp until 581bp (3' promoter, exon1, IVSI, exon2, and 5'IVSII) from *HBA1* gene, and 774bp (3'enhancer) onwards from *HBA2* gene.[@ref8] The region in-between 581bp and 774bp (3' IVSII, exon 3', and 5' enhancer) were matching with *HBA1* and *HBA2*, hence this region was considered as an indistinguishable region.[@ref8] The α-globin protein from *HBA12* gene is not available in the literature, detailed studies are needed to confirm the similarity of *HBA12* protein with the α-globin protein of *HBA2* and *HBA1* genes.
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A total of 5.7% of the study population including sickle cell trait, hemophilia-A patient, SCD patients, and β-thal major patients were reported to have the new gene convert, α~12~ gene. The inheritance of the *HBA12* gene was proven on an elaborated family study, any one of the parent of individual with *HBA12* was a carrier for the *HBA12* gene. The *HBA12* gene was reported to be co-inherited with any one of the common α-globin gene defects like α^3.7^ deletion, ααα^3.7^ triplications, and α^4.2^ deletion, but not always. The reported *HBA12* gene from Saudis was distinguishably different from the α-globin patch works, such as α~212~ and α~121~.[@ref8] Except the nullizygous, all the other 3 types (hemizygous α~1~-/α~1~α~12~, heterozygous α~1~α~2~/α~1~α~12~, and homozygous α~1~α~12~/α~1~α~12~) of zygosities were observed for the α~12~ gene from Saudi population. α-globin gene convert was highly prevalent in the Saudis due to the high percentage of consanguinity. Slight increase in mean corpuscular volume, elevated HbF (α~2~γ~2~), and reduced *HbA~2~* (α~2~δ~2~) were noted on the subjects with α~12~ gene convert.[@ref8]

Alpha~12~ and HbA~2~ {#sec2-3}
====================

Deep analysis by Borgio et al[@ref8] revealed the influence of the α~12~ gene on the level of hemoglobin A~2~ (HbA~2~). Subgrouping the population with the α~12~ gene into 6 groups (HbS^carrier^; β-thal^carrier^; β-thal^major^/α-thal^carrier^; SCD^+ve^, and α-thal^carrier^; HbS^carrier^ α-thal^carrier^; and Normal^No\ α-thal&β-thal^) by the authors was able to identify the reduced level of HbA~2~ in the first 5 groups with α~12~ gene.[@ref8] Thorough investigation on the large-scale micromapping of phenomics for this α~12~ gene is mandatory to uncover the hematologic effects of the new α~12~ gene.

Alpha-globin genotypes {#sec2-4}
======================

The term "α-globin genotype" refers to the genetic makeup of an individual's complete set of α-genes. Two alleles (α/α) at each α-globin gene position is called diploid. In general, 2 pairs of alleles from 2 α-globin genes, α~1~/α~1~ (*HBA1*) and α~2~/α~2~ (*HBA2*) represents the genotype (α~1~α~2~/α~1~α~2~) of an α-globin gene. In terms of Saudi population, the *HBA2* gene has been replaced with *HBA12* gene convert, a pair of alleles α~12~/α~12~ of an α-globin gene convert, *HBA12* specific to Saudis represents the genotype, α~1~α~12~/α~1~α~12~. Hence there are 3 genotypes, α~1~α~2~/α~1~α~2~, α~1~α~2~/α~1~α~12~, and α~1~α~12~/α~1~α~12~ are the possible normal genotypes in Saudi population ([**Table 1**](#T1){ref-type="table"}). There were 32 different genotypes reported from Saudi population ([**Table 1**](#T1){ref-type="table"}). The α-globin genotypes, -α^3.7^/αα, and -α^3.7^/-α^3.7^ are the most prevalent in Saudis.[@ref7],[@ref15] Alpha-globin genotype of each individual contributes to its α-thal phenotype. On the basis of genotypes, α-thal can be classified into 4 types, group one: deletion of 4 α-globin genes, termed Hb Bart's; group 2: deletion of 3 α- globin genes, called HbH disease; group 3: deletion of 2 α- globin genes, named α-thal trait; group 4: deletion of one α-globin gene, designated α-thal Silent ([**Table 1**](#T1){ref-type="table"}, [**Figure 2**](#F2){ref-type="fig"}). Two particular identical alleles are described as homozygous (for example, α^3.7^ homozygous deletion -α^3.7^/-α^3.7^), and if the 2 alleles differ, it is termed as heterozygous (for example, α^3.7^ heterozygous deletion -α^3.7^/αα). Hemizygous (for example, α~1~-^4.2^/α~1~α~12~) form of α-globin genotypes were also reported from Saudis.[@ref8] Severity of the α-thal disorder is indirectly proportional to the number of functional α-globin genes. The severities of α-thal tend to be more in group one results from the loss of all 4 α-globin genes, while signs and symptoms are almost nil in group 4 ([**Figure 2**](#F2){ref-type="fig"}). Techniques for the updated genotyping (the process of determining a genotype) of α-globin genes in Saudis for the proper diagnosis should be given to health professional.

###### 

Alpha-globin genotypes prevalent in Saudi population according to various studies in Saudi Arabia.
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![Molecular types of thalassemia and types of globin gene deletions prevalent in the Saudi population. Filled boxes of genes α1, α2, and α12 indicates normal genes, while empty boxes of genes α1, α2, and α12 indicate the deleted genes.](SaudiMedJ-36-1271-g003){#F2}

Down regulation factors of the α-globin gene expression {#sec2-5}
=======================================================

In general, down regulation of the expression of the α-globin genes due to mutations in *ATRX* (α-thal x-linked mental retardation) gene, usually lead to α-thal like phenotype.[@ref22],[@ref23] Very recently, there were 4 novel mutations (*IVS I-5*(*G*→*C*), *Cd39*(*C*→*T*), *c.623delA*, and *c.848T\>C*) on ATRX gene reported in Saudi population. The 2 exonic mutations (*c.623delA* and *c.848T\>C*) were reported in patients co-inherited with α-globin genes mutations.[@ref9] The study is a clear alarm that the α-thal-like phenotype in Saudi population may be due to mutations in α-globin genes, or in *ATRX* gene. It seems reasonable to suggest that screening for the presence of mutations in the *ATRX* gene along with mutations in the *HBA2*, *HBA1*, and *HBA12* genes are essential for proper identification of the disease burden in this population.

The main limitation of this review is that, some of the articles dealing with α-thal within the Saudi population were not publicly accessible full text scholarly articles. Health sector professional should keep themselves updated with the genotyping techniques for α-globin and *ATRX* genes in Saudis. The very high frequency of α-thal, SCD, and β-thal in the Kingdom and their co-inheritance obliges the addition of sequence based testing system for *HBA2*, *HBA1*, *HBA12*, and *ATRX* genes along with the existing pre-marital testing program, to detect the risk for the offspring of affected individuals.

In conclusion, large-scale screening is mandatory to identify the influence of point mutations and deletion on the phenotype of Saudi population. In-depth, the studies on the prevalence of the sequence variations in α~12~ and their influence on the phenotypes are needed. Comparative studies on the protein structure and molecular modeling of α~1~, α~2~, and α~12~ have to be initiated. Specific diagnostic kits for Saudi population should be developed to identify the sequence defects in α~1~, α~2~, and α~12~ genes. The clinical effects due to the changes in α-globin gene expression from the α~12~ gene should be studied at large-scale. Cellular studies are needed to understand the process of down regulation of α-globin gene expression due to *ATRX* gene mutation in Saudis.
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